A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors Read more about A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer Read more about An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors Read more about PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer Read more about Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer
Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer Read more about Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer
Implementing, a Mhealth Application for HIV Infected and Uninfected Women With Co-morbidities in the Outpatient Setting Read more about Implementing, a Mhealth Application for HIV Infected and Uninfected Women With Co-morbidities in the Outpatient Setting
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread Read more about Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
Comparing Two Methods to Follow Patients With Pancreatic Cysts Read more about Comparing Two Methods to Follow Patients With Pancreatic Cysts
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Read more about Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV Read more about Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV